CTSI licenses GeneGo's pathway analysis suite and database searching tool

GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the Indiana Clinical and Translational Sciences Institute (CTSI) has licensed its pathway analysis suite MetaCore and its database searching tool Eureka. The CTSI is based on a $25 million National Institutes of Health Clinical and Translational Science Award (CTSA) and is a partnership between Indiana University, Purdue University, and the University of Notre Dame. GeneGo will embed its Eureka platform into the CTSI website for use by all CTSI researchers.

The CTSI portal, called the Indiana CTSI HUB (http://www.indianactsi.org/), is a content management system that is designed to be the central clearinghouse for translational research activities for health care researchers at the IU School of Medicine and ultimately across the state of Indiana. The goals of the CTSI are to create research acceleration programs and support pilot projects, train a new cadre of translational researchers, foster robust community engagement, build facile and comprehensive resources and technologies, and leverage the resources of the greater Indiana community.

"A primary goal of the Indiana CTSI Translational Technologies Program (TTR) is to build an infrastructure that enhances the opportunity for our researchers to utilize state-of-the-art technologies. GeneGo's agreement to provide access to their software tools to all investigators across our partner institutions at a cost equivalent to that for a few researchers to purchase their own agreements significantly contributes to this goal and offers an expanded opportunity for inter-campus collaborations," said Lilith Reeves, Chief Scientific Officer, Indiana CTSI, IUSM.  The partner institutions include the Indiana University School of Medicine, Purdue University, University of Notre Dame, Indiana University Bloomington, and Indiana University-Purdue University Indianapolis.

"Eureka is an easy to use 'Google-like' interface that allows researchers to leverage the excellent quality of GeneGo's database in their everyday workflows," said Julie Bryant, VP of Sales and Business Development at GeneGo. "Indiana is on the cutting edge of translational research with its excellent universities and we are pleased to be a part of this."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI in medicine: Revolutionary tools, uncertain results